Breast pathology 2 Flashcards

(50 cards)

1
Q

What are the metastatic tumours to the breast?

A
  • Carcinoma
    • bronchial
    • ovarian serous carcinoma
    • clear cell carcinoma of the kidney
  • malignant melanoma
  • soft tissue tumours
    • leiomyosarcoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define breast carcinoma

A

A malignant tumour of breast epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where does breast carcinoma arise?

A

Glandular epithelium of the terminal duct lobular unit (TDLU)

It is an adenocarcinoma but is usually just referred to as ‘breast carcinoma’

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the precursor lesions of breast carcinoma?

A
  • ductal
    • epithelial hyperplasia of usual type
    • columnar cell change (+/- atypia)
    • atypical ductal hyperplasia
    • ductal carcinoma in situ
  • lobular
    • lobular in situ neoplasia
      • atypical lobular hyperplasia
      • lobular carcinoma in sity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is in situ carcinoma?

A

confined within basement membrane of acini & ducts

Cytologically malignant but non-invasice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is in situ carcinoma a precursor for?

A

Non-obligate precursor of invasive carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is in situ carcinoma classified?

A

Lobular

Ductal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the two classifications of lobular in situ neoplasia?

A

Atypical lobular hyperplasia (ALH) <50% of lobule involved

Lobular carcinoma in situ (LCIS) >50% of lobule involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe intra-lobular proliferation of characteristic neoplastic cells

A
  • small-intermediate sized nuclei
  • solid proliferation
  • intra-cytoplasmic lumens/vacuoles
  • ER positive
  • E-carherine negative (deletion and mutation of CDH1 gene on Chr 16q22.1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lobular in situ neoplasia is frequently ______ and ______.

A

Lobular in situ neoplasia is frequently multifocal and bilateral.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When does the incidence of lobular in situ neoplasia decrease?

A

After menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the significance of lobular in situ neoplasia?

A

relative risk of invasive carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the management of lobular in situ neoplasia?

A

LN discovered on core biopsy

  • proceed to excision or vacuum biopsy to exclude higher grade lesion

LN discovered on vacuum or excison

  • follow up
    • clinical trials*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is intraductal proliferation?

A

Epithelial hyperplasia of usual type

  • Columnar cell change (lesion)
  • Columnar cell change with atypia
  • Atypical ductal hyperplasia
  • Ductal carcinoma in situ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the RR of progression of intraductal proliferation to invasive carcinoma?

A
  • epithelial hyperplasia of usual type= 2 x RR
  • Atypical ductal hyperplasia = 4 x RR
  • Ductal carcinoma in situ (low grade) = 10 x RR
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ductal carcinoma in situ are characteristically ________ (_____ duct system)

A

Ductal carcinoma in situ are characteristically unicentric (single duct system)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe the cytology of DCIS

A

Cytologically malignant epithelial cells confined within basement membrane of duct

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is cancerisation

A

DCIS involving lobules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is paget’s disease of the nipple?

A

DCIS involving the nipple skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Is paget’s disease invasive?

A

No still in situ carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

How is DCIS classified?

A
  • cytological grade
  • histological type
  • presence of necrosis
22
Q

what is the significance of DCIS?

A

risk factor for progression of invasive carcinoma

23
Q

How is DCIS managed?

A
  • diagnosis
  • surgery
    • trials of mammographic follow-up in low risk DCIS
  • adjuvant chemotherapy
  • chemoprevention
    • endocrine therapy
24
Q

What is microinvasive carcinoma?

A

Rare, high grade DCIS with invasion of <1mm

25
How is microinvasive carcinoma treated?
as high grade DCIS
26
What is invasive breast carcinoma?
Malignant epithelial cells have breached the basement membrane Infiltration of normal tissues
27
What is the risk with invasive breast carcinoma?
Metastasis and death
28
What are the risk factors for carcinoma of the breast?
* age * reproductive history * hormones * previous disease * geography * lifestyle * genetics
29
What are the reproductive history risk factors for carcinoma of the breast?
* age at menarche * age at first birth * parity * breastfeeding * age at menopause
30
What hormones affect risk of carcinoma of the breast?
Endogenous Exogenous - OCP - HRT
31
How increased is the risk of breast cancer with OCP use, how long does it take to return to population risk
1.0 -\> 1.24 10 years
32
What aspects of lifestyle contribute to risk of carcinoma of the breast?
* body weight- *higher oestrogen from fatty tissue conversion* * physical activity (protective)- *lowers oestrogen levels* * alcohol consumption- *higher oestrogen levels* * diet- *high fat intake* * NSAID- *reduces risk slightly* * smoking
33
first degree Affected by breast cancer _______ relative risk
doubles
34
What are the cancer syndromes contributing to genetic risk of breast cancer?
* BRCA1- *breast/ovarian predispostion* * BRCA2- *breast/ovarian predisposition* * TP53- *li fraumeni syndrome* * PTEN- *cowden's syndrome* * STK11/LKB1- *peutz-jeghers syndrome* * ATM- *ataxia telengiectasia*
35
What is the lifetime risk of breast cancer with BRCA1 AND 2 mutations?
45-64%
36
What is the net 10 year survival from carcinoma of the breast??
78%
37
What is the commonest female cancer
Invasive breast carcinoma
38
Describe the natural history of invasive breast carcinoma?
* local invasion (T) * stroma of breast * skin * muscles of chest wall * lymphatics (N) * regional draining lymph nodes * Blood-borne (M) * bone, liver, brain, lungs, abdominal viscera, female genital tract
39
Which lymph nodes does the breast drain to?
Internal mammary Intramammary Sentinel nodes Axillary nodes Atypical nodes Infraclavicular nodes Supraclavicular nodes Cervical nodes
40
How can invasive breast cancer be classified morphologically?
Type Grade
41
How can invasive breast cancer be classified through gene expression profiling?
Intrinsic sub-types
42
How can invasive breast cancer be classified through hormone receptor expression?
Oestrogen receptor Progesterone receptor HER2
43
How is breast carcinoma graded?
Objective assessment of; * tubular differentiation (1-3) * nuclear pleomorphism (1-3) * mitotic activity (1-3) Score 3,4 or 5 = grade 1 Score 6 or 7 = grade 2 Score 8 or 9 = grade 3
44
What are the intrinsic breast cancer subtypes?
* basal like: ER-, HER2-, Basal CK+ * HER2: ER-, HER2+ * Normal breast-like: ER-, non-epithelial * Luminal A: ER+, low proliferation * Luminal B: ER+, high proliferation * Luminal C: ER+, high proliferation
45
\_\_% of breast cancers are ER positive \_\_% of breast cancers are PgR positive \_\_% of breast cancers are HER2 positive
**80**% of breast cancers are ER positive **67**% of breast cancers are PgR positive **14**% of breast cancers are HER2 positive
46
What does ER expression predict?
Response to anti-oestrogen therapy - oophorectomy - tamoxifen - aromatase inhibitors (letrozole) - GnRH antagonists (goserlinin [zoladex])
47
What is HER2?
Human epidermal growth factor receptor 2
48
* HER 2 overexpression and amplification seen in ~**\_\_**% * HER 2 overexpression or amplification predict response to **\_\_\_\_\_\_\_\_** (**\_\_\_\_\_\_\_\_**)
* HER 2 overexpression and amplification seen in ~**15**% * HER 2 overexpression or amplification predict response to **trastuzamab** (**herceptin**)
49
What are the predictive and prognostic factors for invasive carcinoma?
ER (PgR) HER2
50
What is the nottingham prognostic index?
* 0.2 x tumour diameter (cm) * Tumour grade (1-3) * Lymph node status (1-3)